North America Pharmacogenetics Testing Market Advances With Rising Demand for Personalized Depression Treatment
" According to the latest report published by Data Bridge Market Research, the North America Pharmacogenetics Testing in Psychiatry/Depression Market  CAGR Value The North America pharmacogenetics testing in psychiatry/depression market was valued at USD 677.59 million in 2025 and is projected to reach USD 1,421.08 million by 2033, growing at a CAGR of 9.7%...
0 Reacties 0 aandelen 61 Views 0 voorbeeld